Growth Metrics

Sarepta Therapeutics (SRPT) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 36.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36.40%
Dec 31, 2025 -46.89%
Sep 30, 2025 44.60%
Jun 30, 2025 40.25%
Mar 31, 2025 -56.50%
Dec 31, 2024 46.65%
Sep 30, 2024 37.21%
Jun 30, 2024 27.42%
Mar 31, 2024 29.68%
Dec 31, 2023 32.32%
Sep 30, 2023 43.12%
Jun 30, 2023 48.09%
Mar 31, 2023 -194.25%
Dec 31, 2022 26.79%
Sep 30, 2022 -20.03%
Jun 30, 2022 10.85%
Mar 31, 2022 -3.90%
Dec 31, 2021 11.31%
Sep 30, 2021 19.50%
Jun 30, 2021 15.15%
Mar 31, 2021 -56.30%
Dec 31, 2020 -86.50%
Sep 30, 2020 -47.44%
Jun 30, 2020 -18.84%
Mar 31, 2020 -29.07%
Dec 31, 2019 -24.95%
Sep 30, 2019 -12.94%
Jun 30, 2019 -40.45%
Mar 31, 2019 6.52%
Dec 31, 2018 -12.49%
Sep 30, 2018 2.74%
Jun 30, 2018 -18.25%
Mar 31, 2018 28.27%
Dec 31, 2017 30.03%
Sep 30, 2017 -3.18%
Jun 30, 2017 -10.60%
Mar 31, 2017 59.27%
Dec 31, 2016 -91.69%
Sep 30, 2016 1.64%
Jun 30, 2016 -31.04%
Mar 31, 2016 0.25%
Dec 31, 2015 15.18%
Sep 30, 2015 16.79%
Jun 30, 2015 -68.75%
Mar 31, 2015 -24.08%
Dec 31, 2014 -162.07%
Sep 30, 2014 -58.00%
Jun 30, 2014 -152.86%
Mar 31, 2014 -111.79%
Dec 31, 2013 46.71%
Sep 30, 2013 -160.68%
Jun 30, 2013 -58.74%